tiprankstipranks
Trending News
More News >
Pascal Biosciences Inc (TSE:NEVI)
:NEVI
Canadian Market

Pascal Biosciences Inc (NEVI) Ratios

Compare
5 Followers

Pascal Biosciences Inc Ratios

TSE:NEVI's free cash flow for Q3 2025 was C$―. For the 2025 fiscal year, TSE:NEVI's free cash flow was decreased by C$ and operating cash flow was C$―. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.92 1.08 0.79 0.02 0.22
Quick Ratio
0.43 0.51 0.57 0.02 0.22
Cash Ratio
0.07 0.23 0.37 <0.01 0.00
Solvency Ratio
0.07 -0.14 -0.26 -0.49 -1.66
Operating Cash Flow Ratio
0.01 -0.21 -0.34 -0.17 -0.95
Short-Term Operating Cash Flow Coverage
0.02 -0.42 -0.56 -0.66 -79.25
Net Current Asset Value
C$ -55.15KC$ -192.75KC$ -237.43KC$ -944.11KC$ -501.28K
Leverage Ratios
Debt-to-Assets Ratio
0.24 0.26 0.27 11.93 0.05
Debt-to-Equity Ratio
0.38 0.43 0.50 -0.24 -0.02
Debt-to-Capital Ratio
0.28 0.30 0.33 -0.31 -0.02
Long-Term Debt-to-Capital Ratio
0.00 0.16 0.00 0.00 0.00
Financial Leverage Ratio
1.61 1.66 1.81 -0.02 -0.32
Debt Service Coverage Ratio
0.20 -0.14 -0.39 -2.08 -79.96
Interest Coverage Ratio
-1.23 -3.50 0.00 0.00 -193.56
Debt to Market Cap
0.26 0.13 0.36 0.17 <0.01
Interest Debt Per Share
0.01 0.02 0.03 0.02 <0.01
Net Debt to EBITDA
3.92 -8.29 -0.99 -0.46 >-0.01
Profitability Margins
Gross Profit Margin
75.34%69.45%58.51%0.00%0.00%
EBIT Margin
-7.86%-19.32%-56.36%0.00%0.00%
EBITDA Margin
6.61%-3.10%-39.75%0.00%0.00%
Operating Profit Margin
-4.23%-14.20%-129.27%0.00%0.00%
Pretax Profit Margin
-13.12%-23.39%-59.53%0.00%0.00%
Net Profit Margin
-13.12%-23.39%-59.53%0.00%0.00%
Continuous Operations Profit Margin
-13.12%-23.39%-59.53%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
310.33%164.65%46.05%86.24%100.73%
Return on Assets (ROA)
-10.58%-17.78%-16.02%-2551.56%-701.69%
Return on Equity (ROE)
-16.45%-29.58%-29.05%50.87%221.65%
Return on Capital Employed (ROCE)
-5.48%-15.01%-63.07%66.90%220.04%
Return on Invested Capital (ROIC)
-3.97%-12.55%-42.15%91.63%223.57%
Return on Tangible Assets
-29.57%-56.36%-44.35%-2551.56%-701.69%
Earnings Yield
-11.53%-9.01%-21.24%-36.64%-20.18%
Efficiency Ratios
Receivables Turnover
6.43 9.97 3.25 0.00 0.00
Payables Turnover
0.00 1.66 0.86 0.05 0.05
Inventory Turnover
1.07 1.43 1.12 0.00 0.00
Fixed Asset Turnover
91.70 69.27 33.88 0.00 0.00
Asset Turnover
0.81 0.76 0.27 0.00 0.00
Working Capital Turnover Ratio
-19.71 -16.38 -1.26 0.00 0.00
Cash Conversion Cycle
399.33 72.19 14.56 -6.73K -7.94K
Days of Sales Outstanding
56.74 36.62 112.42 0.00 0.00
Days of Inventory Outstanding
342.60 255.39 325.26 0.00 0.00
Days of Payables Outstanding
0.00 219.82 423.12 6.73K 7.94K
Operating Cycle
399.33 292.01 437.68 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 >-0.01 -0.02 -0.01 -0.05
Free Cash Flow Per Share
<0.01 >-0.01 -0.02 -0.01 -0.05
CapEx Per Share
<0.01 <0.01 <0.01 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.10 1.01 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
2.39K -10.42 -74.93 0.00 0.00
Capital Expenditure Coverage Ratio
2.39K -10.42 -74.93 0.00 0.00
Operating Cash Flow Coverage Ratio
0.02 -0.23 -0.56 -0.66 -79.25
Operating Cash Flow to Sales Ratio
<0.01 -0.08 -0.57 0.00 0.00
Free Cash Flow Yield
0.53%-3.28%-20.75%-11.27%-11.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-8.67 -11.10 -4.71 -2.73 -4.96
Price-to-Sales (P/S) Ratio
1.14 2.60 2.80 0.00 0.00
Price-to-Book (P/B) Ratio
1.47 3.28 1.37 -1.39 -10.98
Price-to-Free Cash Flow (P/FCF) Ratio
186.93 -30.47 -4.82 -8.88 -8.78
Price-to-Operating Cash Flow Ratio
186.85 -33.40 -4.88 -8.88 -8.78
Price-to-Earnings Growth (PEG) Ratio
-0.42 0.25 0.09 0.05 0.23
Price-to-Fair Value
1.47 3.28 1.37 -1.39 -10.98
Enterprise Value Multiple
21.14 -92.01 -8.04 -3.26 -5.06
Enterprise Value
2.19M 4.42M 2.15M 1.53M 5.40M
EV to EBITDA
21.14 -92.01 -8.04 -3.26 -5.06
EV to Sales
1.40 2.85 3.20 0.00 0.00
EV to Free Cash Flow
229.47 -33.49 -5.50 -10.34 -8.79
EV to Operating Cash Flow
229.37 -36.71 -5.57 -10.34 -8.79
Tangible Book Value Per Share
>-0.01 >-0.01 >-0.01 -0.07 -0.04
Shareholders’ Equity Per Share
0.03 0.03 0.06 -0.07 -0.04
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 <0.01 <0.01
Revenue Per Share
0.04 0.04 0.03 0.00 0.00
Net Income Per Share
>-0.01 >-0.01 -0.02 -0.04 -0.09
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.67 1.21 1.06 1.01 1.01
Research & Development to Revenue
0.00 0.00 0.05 0.00 0.00
SG&A to Revenue
0.50 0.50 1.41 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.61 0.00 0.00
Income Quality
-0.05 0.33 0.96 0.31 0.56
Currency in CAD